ATX/ AT0000999982
ATX2024-04-17 5:50:01 PM | Chg. +10.57 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
3,507.97XXP | +0.30% | 3,498.02 | 3,525.01 | 3,494.79 | 3,497.40 |
|
Newsfile Corp
04-09
THE Mining Investment Event of the North, Quebec City - June 4-6, 2024 Announces Keynote Speaker, Ma...
GlobeNewswire
04-02
MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered ...
GlobeNewswire
03-12
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
GlobeNewswire
03-04
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
Newsfile Corp
03-04
THE Mining Investment Event of the North, Quebec City - June 4-6, 2024 Announces Glencore Canada as ...
Newsfile Corp
02-29
THE Mining Investment Event of the North, Quebec City - June 4-6, 2024 Announces Keynote Speaker, Pi...
GlobeNewswire
02-09
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Particip...
GlobeNewswire
01-30
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Ma...
GlobeNewswire
01-23
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
GlobeNewswire
01-08
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
01-03
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline
GlobeNewswire
01-02
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
GlobeNewswire
2023-11-14
AMD Expands Ryzen Embedded Processor Family for High-Performance Industrial Automation, Machine Vis...
GlobeNewswire
2023-11-13
Breezeline Supports Graduate Students in Broadband Equity Challenge Competition
GlobeNewswire
2023-11-08
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
GlobeNewswire
2023-10-04
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
GlobeNewswire
2023-09-06
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing